RGT 1.32% 37.5¢ argent biopharma limited

Ann: Retraction of Statement, page-12

  1. 1,268 Posts.
    lightbulb Created with Sketch. 107
    " Our approach combines in-house research with innovative technologies, all aimed at discovering and producing treatments for currently unmet medical conditions. ...Our central business strategy revolves around the development and supply of innovative medicines, responding to the increasing demand in the medical markets of Europe, North America, and Australasia."

    what are the "unmet" medical conditions? Probably death would be one haha hasnt been cured yet. What else is there is that can be but isn't being treated by something. There are a lot of psychological conditions where need for treatment is unmet but that's not what MGC does. What do they mean by "unmet". Maybe they will have to first create these medical conditions for which there is no or not enough treatment yet. I'm really ignorant now about what MGC are doing that is innovative and what unmet medical condition needs they intend to meet, and where will they meet them.
    Last edited by VMG70: 26/12/23
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
-0.005(1.32%)
Mkt cap ! $16.98M
Open High Low Value Volume
38.0¢ 38.0¢ 37.5¢ $349 919

Buyers (Bids)

No. Vol. Price($)
2 2399 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 2550 2
View Market Depth
Last trade - 15.50pm 16/05/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.